Cristina Rodríguez-Prado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cristina Rodríguez-Prado has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Natsuki Oishi
Faculty of Medicine and Odontology, Valencia University, 46010 Valencia, Spain
6 shared publications - Enrique Zapater
Faculty of Medicine and Odontology, Valencia University, 46010 Valencia, Spain
5 shared publications - Jose Ramón Alba
ENT Department, Valencia University General Hospital, 46014 Valencia, Spain
4 shared publications - R. Reboll
ENT Department Valencia University General Hospital, Valencia, Spain
2 shared publications - Rosa Hernández-Sandemetrio
Faculty of Medicine and Odontology, Valencia University, 46010 Valencia, Spain
2 shared publications - Ainhoa García-Lliberós
Servicio de Otorrinolaringología y Cirugía de Cabeza y Cuello, Hospital General Universitario de Valencia, Valencia, Spain
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature
- 9 October 2026
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
Open AccessSolitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature
- Open Access
- 27 August 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 12 (5) , 645-654
Generative AI and Clinicians Show Comparable Prognostic Reasoning From Clinical Narratives in Biologic‐Treated CRSwNP
Objective: To compare the ability of large language models (LLMs) and otolaryngologists to identify prognostic signals from brief clinical vignettes in CRSwNP. Methods: In this blinded study, 68 adults initiating biologic therapy for CRSwNP (≥ 36 months follow‐up) were represented by standardized vignettes derived from documentation immediately before biologic initiation. Vignettes summarized symptoms, prior surgery, comorbidities, and medications. Biomarkers, imaging scores, smell testing, and follow‐up data were excluded to isolate text‐based prognostic reasoning under identical constraints. Five attending otolaryngologists, one rhinology fellow, and two residents independently predicted four 5‐year outcomes: subsequent endoscopic sinus surgery, recurrent systemic steroid bursts, biologic switch, and a composite endpoint. Multiple LLMs were queried in identical zero‐shot format across three sessions to assess stability. Predictions were compared with verified outcomes using accuracy, sensitivity, specificity, F1 score, Cohen's κ, and Matthews correlation coefficient. Results: Five‐year outcome prevalences were 38.2% (26 of 68) for subsequent sinus surgery, 26.5% (18 of 68) for steroid bursts, 14.7% (10 of 68) for biologic switch, and 58.8% (40 of 68) for composite failure. Macro‐averaged LLM accuracies ranged from 65.0% to 76.1%, compared with 65.7% ± 7.4% for human raters. The best‐performing LLM achieved accuracy comparable to the top attending. Both groups showed higher negative than positive predictive values, indicating better discrimination for patients without adverse events. Agreement between LLMs and clinicians was moderate and within the range of inter‐clinician variability. Conclusion: When restricted to short pretreatment text, LLMs produced prognostic judgments within the range of clinician variability for severe, biologic‐treated CRSwNP outcomes. These findings suggest that in information‐limited settings, LLMs may provide an auxiliary reasoning signal rather than a standalone decision tool.
- 27 August 2026
- Published by Wiley in World Journal of Otorhinolaryngology - Head and Neck Surgery
- Vol. 12 (5) , 645-654
Open AccessGenerative AI and Clinicians Show Comparable Prognostic Reasoning From Clinical Narratives in Biologic‐Treated CRSwNP
Objective: To compare the ability of large language models (LLMs) and otolaryngologists to identify prognostic signals from brief clinical vignettes in CRSwNP. Methods: In this blinded study, 68 adults initiating biologic therapy for CRSwNP (≥ 36 months follow‐up) were represented by standardized vignettes derived from documentation immediately before biologic initiation. Vignettes summarized symptoms, prior surgery, comorbidities, and medications. Biomarkers, imaging scores, smell testing, and follow‐up data were excluded to isolate text‐based prognostic reasoning under identical constraints. Five attending otolaryngologists, one rhinology fellow, and two residents independently predicted four 5‐year outcomes: subsequent endoscopic sinus surgery, recurrent systemic steroid bursts, biologic switch, and a composite endpoint. Multiple LLMs were queried in identical zero‐shot format across three sessions to assess stability. Predictions were compared with verified outcomes using accuracy, sensitivity, specificity, F1 score, Cohen's κ, and Matthews correlation coefficient. Results: Five‐year outcome prevalences were 38.2% (26 of 68) for subsequent sinus surgery, 26.5% (18 of 68) for steroid bursts, 14.7% (10 of 68) for biologic switch, and 58.8% (40 of 68) for composite failure. Macro‐averaged LLM accuracies ranged from 65.0% to 76.1%, compared with 65.7% ± 7.4% for human raters. The best‐performing LLM achieved accuracy comparable to the top attending. Both groups showed higher negative than positive predictive values, indicating better discrimination for patients without adverse events. Agreement between LLMs and clinicians was moderate and within the range of inter‐clinician variability. Conclusion: When restricted to short pretreatment text, LLMs produced prognostic judgments within the range of clinician variability for severe, biologic‐treated CRSwNP outcomes. These findings suggest that in information‐limited settings, LLMs may provide an auxiliary reasoning signal rather than a standalone decision tool.
- 30 January 2026
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 143 (1) , 12-14
Republication de : Vestibulectomy prior cordectomy in tomes: Advantages and dysplasia findings
- 30 January 2026
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 143 (1) , 12-14
Republication de : Vestibulectomy prior cordectomy in tomes: Advantages and dysplasia findings
- 1 October 2025
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 76 (6) , 512271
Validation of the self-assessment questionnaire for patients with unilateral vocal cord paralysis (PVU-HI-10) in Spanish
- 1 October 2025
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 76 (6) , 512271
Validation of the self-assessment questionnaire for patients with unilateral vocal cord paralysis (PVU-HI-10) in Spanish
- Open Access
- 1 October 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (10) , 465
Transoral Cordectomy with Microelectrodes (TOMES) on an Outpatient Basis: Advancing Patient Comfort and Personalized Care Through Predictive Models
Background/Objectives: Outpatient surgery enhances patient comfort while reduces surgical wait times and healthcare costs compared to inpatient procedures. This study evaluates the individual feasibility of performing transoral trans muscular cordectomies with microelectrodes (TOMES) on an outpatient basis. Methods: This observational study analyses TOMES types III, IV, and V cordectomies performed from January 2002 to December 2023. Key metrics include patient demographics, procedural details, incidence of bleeding, anticoagulation and other comorbidities. Results: Of the 143 procedures, 127 were cancer-related, while 16 were due to bilateral vocal cord paralysis. The average age was 65, with a predominantly male cohort (92%). Postoperative hemorrhage occurred in four cases, primarily among oncological patients, but there was no correlation with anticoagulation therapy. A personalized predictive model for bleeding risk was developed based on patient-specific characteristics and observed outcomes. Additionally, performing the procedure on an outpatient basis decreased healthcare costs and wait times for patients with T1/T2 glottic carcinoma. Conclusions: The findings indicate that TOMES type III or higher cordectomies can be safely performed on an outpatient basis, through the use of a personalized predictive model for each case and with appropriate postoperative monitoring. This approach has the potential to lower healthcare costs and improve patient quality of life through individualized assessments and structured risk analysis.
- 1 October 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (10) , 465
Open AccessTransoral Cordectomy with Microelectrodes (TOMES) on an Outpatient Basis: Advancing Patient Comfort and Personalized Care Through Predictive Models
Background/Objectives: Outpatient surgery enhances patient comfort while reduces surgical wait times and healthcare costs compared to inpatient procedures. This study evaluates the individual feasibility of performing transoral trans muscular cordectomies with microelectrodes (TOMES) on an outpatient basis. Methods: This observational study analyses TOMES types III, IV, and V cordectomies performed from January 2002 to December 2023. Key metrics include patient demographics, procedural details, incidence of bleeding, anticoagulation and other comorbidities. Results: Of the 143 procedures, 127 were cancer-related, while 16 were due to bilateral vocal cord paralysis. The average age was 65, with a predominantly male cohort (92%). Postoperative hemorrhage occurred in four cases, primarily among oncological patients, but there was no correlation with anticoagulation therapy. A personalized predictive model for bleeding risk was developed based on patient-specific characteristics and observed outcomes. Additionally, performing the procedure on an outpatient basis decreased healthcare costs and wait times for patients with T1/T2 glottic carcinoma. Conclusions: The findings indicate that TOMES type III or higher cordectomies can be safely performed on an outpatient basis, through the use of a personalized predictive model for each case and with appropriate postoperative monitoring. This approach has the potential to lower healthcare costs and improve patient quality of life through individualized assessments and structured risk analysis.
- 19 August 2025
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 143 (1) , 11-13
Vestibulectomy prior cordectomy in tomes: Advantages and dysplasia findings
- 19 August 2025
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 143 (1) , 11-13
Vestibulectomy prior cordectomy in tomes: Advantages and dysplasia findings
- 17 March 2025
- Published by Elsevier in Journal of Voice
Phonatory and Radiological Analysis in Modified Montgomery Thyroplasty
- 17 March 2025
- Published by Elsevier in Journal of Voice
Phonatory and Radiological Analysis in Modified Montgomery Thyroplasty
- Open Access
- 8 December 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (2) , 104142
Modified Montgomery thyroplasty: Customisation of the cartilage window according to laryngeal anatomy
- 8 December 2023
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 45 (2) , 104142
Open AccessModified Montgomery thyroplasty: Customisation of the cartilage window according to laryngeal anatomy